Missing content? – Request curation!
Request curation for specific Genes, Variants, or PubMed publications.
Have questions, comments, or suggestions? - Let us know!
Email us at : ckbsupport@genomenon.com
NCT ID | NCT01742988 |
Title | Study to Assess the Safety, Tolerability and Pharmacokinetics of Fimepinostat (CUDC-907) in Patients With Lymphoma |
Recruitment | Completed |
Gender | both |
Phase | Phase Ib/II |
Variant Requirements | No |
Sponsors | Curis, Inc. |
Indications | |
Therapies | |
Age Groups: | adult | senior |
Covered Countries | USA |
Facility | Status | City | State | Zip | Country | Details |
---|---|---|---|---|---|---|
USC/Norris Comprehensive Cancer Center | Los Angeles | California | 90033 | United States | Details | |
Florida Cancer Specialists | Sarasota | Florida | 34232 | United States | Details | |
Winship Cancer Institute, Emory University | Atlanta | Georgia | 30322 | United States | Details | |
University of Chicago Medicine | Chicago | Illinois | 60637 | United States | Details | |
University of Michigan | Ann Arbor | Michigan | 48109 | United States | Details | |
Memorial Sloan-Kettering Cancer Center | New York | New York | 10065 | United States | Details | |
Stephenson Cancer Center, University of Oklahoma Health Sciences Center | Oklahoma City | Oklahoma | 73104 | United States | Details | |
Hospital of the University of Pennsylvania | Philadelphia | Pennsylvania | 19104 | United States | Details | |
Sarah Cannon Research Institute | Nashville | Tennessee | 37203 | United States | Details | |
MD Anderson Cancer Center | Houston | Texas | 77030 | United States | Details | |
Swedish Cancer Institute | Seattle | Washington | 98104 | United States | Details |